Desipramine induces yawning behaviour in rats

Area of Science:

• Neuropharmacology
• Behavioral Neuroscience

Background:

• Yawning is a complex behavior with poorly understood neurobiological underpinnings.
• Antidepressant medications are known to modulate various neurotransmitter systems, including dopamine.

Purpose of the Study:

• To investigate the effect of antidepressant drugs on yawning behavior in rats.
• To elucidate the neurochemical mechanisms underlying drug-induced yawning, particularly the role of the dopaminergic system.

Main Methods:

• Rats were administered various antidepressant drugs and dopamine-related agents subcutaneously.
• Yawning behavior was quantified through direct observation over time.
• Dose-response relationships and the effects of receptor antagonists/inhibitors were analyzed.

Main Results:

• Desipramine induced yawning in a dose-dependent manner with a bell-shaped curve, peaking at 10 mg/kg.
• Dopaminergic antagonists (haloperidol, spiperone, pimozide) significantly reduced desipramine-induced yawning.
• Other antidepressants like imipramine and trazodone also induced yawning, but to a lesser extent than desipramine.

Conclusions:

• Desipramine-induced yawning in rats is mediated by a dopaminergic mechanism.
• Endogenous dopamine is essential for the occurrence of desipramine-induced yawning.
• Certain antidepressant drugs may exert their effects, in part, through modulation of the dopaminergic system.